print small

Participating Countries:

Algeria

Argentina

Australia

Austria

Belgium

Bosnia and Herzegovina

Bulgaria

Croatia

Czech Republic

Denmark

Finland

France

FYR of Macedonia

Germany

Greece

Iceland

Ireland

Israel

Italy

Lithuania

Morocco

Netherlands

New Zealand

Poland

Portugal

Romania

Russian Federation

Serbia

Slovenia

Spain

Sweden

Switzerland

Turkey

Ukraine

United Kingdom

United States

Member area provided by LTFE
COST is supported by the EU Framework Programme Horizon 2020
This website is supported by COST

The Chaim Sheba Medical Center - Elad Maor Lab

Tell your friend  | 

The Chaim Sheba Medical Center
52621 Tel Hashomer
Israel

Contact email:

Visit the website.

Brief presentation of the institution

The Sheba Medical Center at Tel Hashomer is a university-affiliated tertiary referral hospital that serves as Israel's national medical center in many fields. Adjacent to Tel Aviv, it is the most comprehensive medical center in the Middle East, renowned for its compassionate care and leading-edge medicine. It is also a major medical-scientific research powerhouse that collaborates internationally with the bio-tech and pharmaceutical industries to develop new drugs, treatments and technologies, and a foremost global center for medical education.

 

Today, the Sheba Medical Center combines six major facilities: a vast medical research complex, medical education academic campus, acute care hospital, children's hospital, women's hospital and the country's main rehabilitation hospital.
 

Main Electroporation related topics

Dr. Elad Maor is currently a cardiology fellow at the Leviev heart center, with a special interest in cardiovascular medicine and physical sciences. Dr. Maor completed his B. Med. Sc. with distinction and his M.D. at the Joyce and Irving Goldman Medical School of Ben-Gurion University. He then completed his rotating internship at the Sheba Medical Center. Later, Dr. Maor completed one year of research fellowship at the Neufeld Cardiac Research Institute (Tel-Aviv University). His research focused on cardiovascular biology, stem cell biology and regenerative
medicine. Dr. Maor continued his research at the Biophysics graduate group of the University of California at Berkeley, where he completed his PhD in biophysics.

 

 

Dr Maor's research during his PhD studies focused on the biophysical phenomenon of irreversible electroporation. Irreversible electroporation is an emerging cell ablation approach based on the biophysical phenomenon of electroporation. When cells are exposed to an external electric field, pores are created across the phospholipid bilayer. The pores increase membrane's permeability to ions and large molecules and if cells succumb to the change in the intra-cellular environment, the process is called irreversible electroporation (IRE). Irreversible electroporation can destroy cells within seconds, with minimal temperature increase and with no thermal damage to extra-cellular components of the ablated tissue. Dr Maor's work at the biophysics graduate program focused on finite element simulation of endovascular IRE. In addition, he developed a novel endovascular IRE prototype, with possible applications in the field of clinical cardiology.

Main Electroporation related research techniques and equipment

/

Research topics, techniques and equipment not related to Electroporation

Brief information on available facilites

Willingness to accept/host visiting researchers

Members:

Project Office

Working groups

Steering Committee

Founding members

DC Rapporteurs

Related sites: